Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

KELOWNA, BC / ACCESS Newswire / January 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to provi ...

A federal judge has effectively lifted a Saturday deadline for a B.C. farm to kill about 400 ostriches hit by an outbreak of ...

Highlights faulty FDA review WASHINGTON, Jan. 27, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provides an update on the tradipitant ...

It is fair to say that each president’s exercise of the pardon power pushed the outer limits of legitimacy. In fact, the ...

In a significant boost for educational opportunities, the Wapenamanda District in Enga Province will now have a direct ...

The Madras High Court recently allowed the construction of a Bible Study Centre by the District Secretary of the CSI Church ...

Two much-watched advanced nuclear fuel technology companies—Oklo and Lightbridge—will consider co-locating their commercial ...

They apply directly through the page of the course they wish to study via the 'apply ... special entry procedures and require application before 1st February so that they can be included in these ...

Further, EC submissions can occur in parallel with the regulatory submission of clinical trial application ... the approval letter from the IEC (for a multi-centre study, approvals from all ...